In this situation, the incorporation of cannabinoids may reduce opioid dependence and tolerance development; (3) treatment of inflammatory conditions, for example, CB2-targeted compounds hold promise for rheumatoid arthritis, IBD, and other inflammatory diseases. Here, CNR2 is linked to rheumatoid arthritis.